Novocure Ltd.
(NASDAQ : NVCR)

( )
NVCR PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.93%410.471.0%$494.69m
DHRDanaher Corp. -1.64%202.040.7%$478.52m
ISRGIntuitive Surgical, Inc. -0.42%683.002.4%$466.38m
MDTMedtronic Plc 0.32%100.370.6%$461.43m
ABTAbbott Laboratories -1.19%100.030.8%$457.24m
INOInovio Pharmaceuticals, Inc. -6.08%18.996.3%$417.97m
DXCMDexCom, Inc. -4.42%421.227.9%$380.10m
BDXBecton, Dickinson & Co. 0.12%256.721.0%$327.07m
BSXBoston Scientific Corp. 0.03%38.981.0%$312.07m
VARVarian Medical Systems, Inc. -0.20%173.479.1%$285.04m
ALGNAlign Technology, Inc. -0.95%302.916.4%$270.21m
BAXBaxter International, Inc. 2.95%83.111.8%$270.07m
SYKStryker Corp. -2.07%187.581.3%$262.44m
EWEdwards Lifesciences Corp. -1.59%75.720.4%$206.26m
QDELQuidel Corp. -15.79%229.697.7%$180.86m

Company Profile

NovoCure Ltd. develops treatment for tumors. Its platform is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.